Alkermes plc
ALKS
Ранг среди акций
#2726
Alkermes plc, a biopharmaceutical company, engages in the research,... Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
Цена акции
$41.39
Последняя синхронизация: 2026-10-16
Рыночная капитализация
$6.94B
Изменение (1 день)
3.22%
Изменение (1 год)
36.78%
Страна
IE
Торговля Alkermes plc (ALKS)
Категория
Healthcare
Операционная маржа для Alkermes plc (ALKS)
Операционная маржа на October 2026 TTM: 7.03%
Согласно последним финансовым отчетам и цене акций Alkermes plc, текущая операционная маржа (TTM) составляет 7.03%. В конце 2023 она составила 24.90%.
История операционной маржи Alkermes plc с 2000 по 2026
Операционная маржа на конец каждого года
| Год | Операционная маржа | Изменить |
|---|---|---|
| 2026 (TTM) | 7.03% | -73.96% |
| 2024 | 27.00% | 8.43% |
| 2023 | 24.90% | -4,627.27% |
| 2022 | -0.55% | -106.60% |
| 2021 | 8.33% | -176.99% |
| 2020 | -10.82% | -27.82% |
| 2019 | -14.99% | 65.45% |
| 2018 | -9.06% | -44.65% |
| 2017 | -16.37% | -41.49% |
| 2016 | -27.98% | -21.62% |
| 2015 | -35.70% | 153.55% |
| 2014 | -14.08% | -199.09% |
| 2013 | 14.21% | 0.00% |
| 2012 | 14.21% | -162.77% |
| 2011 | -22.64% | -7.40% |
| 2010 | -24.45% | 1.28% |
| 2009 | -24.14% | -158.46% |
| 2008 | 41.29% | -3,659.48% |
| 2007 | -1.16% | -125.22% |
| 2006 | 4.60% | -43.90% |
| 2005 | 8.20% | -108.51% |
| 2004 | -96.39% | -61.15% |
| 2003 | -248.12% | 42.63% |
| 2002 | -173.96% | 50.88% |
| 2001 | -115.30% | 116.00% |
| 2000 | -53.38% | 0.00% |
Операционная маржа для аналогичных компаний или конкурентов
| Компания | Операционная маржа | Разница в операционной марже | Страна |
|---|---|---|---|
| 38.59% | -94.51% |
US
|
|
| -149.01% | -121.20% |
US
|
|
| 25.57% | -96.36% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -95.90% |
NL
|
Что такое операционная маржа компании?
Операционная маржа — это ключевой показатель прибыльности компании. Более высокая операционная маржа обычно означает, что компания может продавать свои товары или услуги значительно дороже их себестоимости. Она рассчитывается путем деления прибыли компании на её выручку.